Drug Shortage Report for BIO-FUROSEMIDE
| Report ID | 18772 |
| Drug Identification Number | 02247372 |
| Brand name | BIO-FUROSEMIDE |
| Common or Proper name | FUROSEMIDE |
| Company Name | BIOMED PHARMA |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | FUROSEMIDE |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | C03CA |
| ATC description | HIGH-CEILING DIURETICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2015-10-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2017-10-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2017-09-20 | French | Compare |
| v3 | 2017-09-20 | English | Compare |
| v2 | 2017-08-11 | French | Compare |
| v1 | 2017-08-11 | English | Compare |
Showing 1 to 4 of 4